Activation of ATP/UTP-selective receptors increases blood flow and blunts sympathetic vasoconstriction in human skeletal muscle

Journal of Physiology

Volumn 586, Issue 20, 2008, Pages 4993-5002

  Rosenmeier, Jaya B ^a   Yegutkin, Gennady G ^b   González Alonso, José ^a,c  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b UNIVERSITY OF TURKU   (Finland)

^c BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; NORADRENALIN; NUCLEOTIDASE; TYRAMINE; URIDINE TRIPHOSPHATE; PURINERGIC P2Y2 RECEPTOR;

ADRENERGIC SYSTEM; ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; ENZYME ACTIVITY; EXERCISE; HEART OUTPUT; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HYPEREMIA; LEG BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; MUSCLE BLOOD FLOW; MUSCLE BLOOD VESSEL; NORADRENALIN BLOOD LEVEL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SKELETAL MUSCLE; VASOCONSTRICTION; VASODILATATION; VENOUS OXYGEN TENSION; FEMORAL ARTERY; NORADRENALIN RELEASE; PROTEIN DEPHOSPHORYLATION;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ADULT; BLOOD FLOW VELOCITY; HUMANS; HYPEREMIA; LEG; MALE; MUSCLE, SKELETAL; PHYSICAL EXERTION; RECEPTORS, CELL SURFACE; RECEPTORS, PURINERGIC P2; REST; SYMPATHETIC NERVOUS SYSTEM; TYRAMINE; VASOCONSTRICTION; VASODILATION;

EID: 54049092445     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2008.155432     Document Type: Article

References (48)

1. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA & Weisman GA (2006). International Union of Pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy. Pharm Rev 58, 281-341.
2. Bogert LW & van Lieshout JJ (2005). Non-invasive pulsatile arterial pressure and stroke volume changes from the human finger. Exp Physiol 90, 437-446.
3. Buckwalter JB, Naik JS, Valic Z & Clifford PS (2001). Exercise attenuates α-adrenergic-receptor responsiveness in skeletal muscle vasculature. J Appl Physiol 90, 172-178.
4. Burnstock G & Kennedy C (1986). A dual function for adenosine 5′-triphosphate in the regulation of vascular tone. Excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent. Circ Res 58, 319-330.
5. Busse R, Edwards G, Feletou M, Flemming I, Vanhoutte PM & Weston AH (2002). EDHF: Bringing the concepts together. Trends Pharmacol Sci 23, 374-380.
6. Collins DM, McCullough WT & Ellsworth ML (1998). Conducted vascular responses: Communication across the capillary bed. Microvasc Res 56, 43-53.
7. Dinenno FA & Joyner MJ (2003). Blunted sympathetic vasoconstriction in contracting skeletal muscle of healthy humans: Is nitric oxide obligatory? J Physiol 553, 281-292.
8. Drury AN & Szent-Gyorgyi A (1929). The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 68, 213-237.
9. Erlinge D & Burnstock G (2008). P2 receptors in cardiovascular regulation and disease. Purinergic Signal 4, 1-20.
10. Erlinge D, Harnek J, van Heusden C, Olivecrona G, Jern S & Lazarowski E (2005). Uridine triphosphate (UTP) is released during cardiac ischemia. Int J Cardiol 100, 427-433.
11. Esler MD, Jennings G, Lambert G, Meredith I, Horne M & Eisenhofer G (1990). Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 70, 963-985.
12. González-Alonso J, Mortensen SP, Dawson EA, Secher NH & Damsgaard R (2006). Erythrocytes and the regulation of human skeletal muscle blood flow and oxygen delivery: Role of erythrocyte count and oxygenation state of haemoglobin. J Physiol 572, 295-305.
13. González-Alonso J, Mortensen SP, Jeppesen TD, Ali L, Barker H, Damsgaard R, Secher NH, Dawson EA & Dufour SP (2008). Haemodynamic responses to exercise, ATP infusion and thigh compression in humans: insight into the role of muscle mechanisms on cardiovascular function. J Physiol 586, 2405-2417.
14. González-Alonso J, Olsen DB & Saltin B (2002). Erythrocyte and the regulation of human skeletal muscle blood flow and oxygen delivery: Role of circulating ATP. Circ Res 91, 1046-1055.
15. González-Alonso J, Quistorff B, Krustrup P, Bangsbo J & Saltin B (2000). Heat production in human skeletal muscle at the onset of intense dynamic exercise. J Physiol 524, 603-615.
16. Gordon JL (1986). Extracellular ATP: Effects, sources and fate. Biochem J 233, 309-319.
17. Hallman H, Farnebo LO, Hamberger B & Johnsson G (1978). A sensitive method for the determination of plasma catecholamines using liquid chromatography with electrochemical detection. Life Sci 23, 1049-1052.
18. Hanada A, Sander M & González-Alonso J (2003). Human skeletal muscle sympathetic activity, heart rate and limb haemodynamics with reduced blood oxygenation and exercise. J Physiol 551, 635-647.
19. Hellsten Y, Maclean D, Rådegran G, Saltin B & Bangsbo J (1998). Adenosine concentrations in the interstitium of resting and contracting human skeletal muscle. Circulation 98, 6-8.
20. 4 receptor. Mol Pharmacol 57, 926-931.
21. Kirby BS, Voyles WF, Carlson RE & Dinenno FA (2008). Graded sympatholytic effect of ATP on postjunctional a-adrenergic vasoconstriction in the human forearm: Implications for vascular control in contracting muscle. J Physiol 586, 4305-4316.
22. Lundin A (2000). Use of firefly luciferase in ATP-related assays of biomass, enzymes, and metabolites. Methods Enzymol 305, 346-370.
23. MacLean DA, Sinoway LI & Leuenberger U (1998). Systemic hypoxia elevates skeletal muscle interstitial adenosine levels in humans. Circulation 98, 1990-1992.
24. Mo FM & Ballard HJ (2001). The effect of systemic hypoxia on interstitial and blood adenosine, AMP, ADP and ATP in dog skeletal muscle. J Physiol 536, 593-603.
25. Mortensen SP, González-Alonso J, Damsgaard R, Saltin B & Hellsten Y (2007). Inhibition of nitric oxide and prostaglandins, but not endothelial-derived hyperpolarizing factors, reduces blood flow and aerobic energy turnover in the exercising human leg. J Physiol 581, 853-861.
26. Murrant CL & Sarelius IH (2002). Multiple dilator pathways in skeletal muscle contraction-induced arteriolar vasodilation. Am J Physiol Regul Integr Comp Physiol 282, R969-R978.
27. Olearczyk JJ, Stephenson AH, Lonigro AJ & Sprague RS (2004). NO inhibits signal transduction pathway for ATP release from erythrocytes via its action on heterotrimeric G protein G i. Am J Physiol Heart Circ Physiol 287, H748-H754.
28. Ralevic V & Burnstock G (1998). Receptors for purines and pyrimidines. Pharmacol Rev 50, 413-492.
29. Ralevic V & Burnstock G (2003). Involvement of purinergic signaling in cardiovascular diseases. Drug News Perspect 16, 133-140.
30. Remensnyder JP, Mitchell JH & Sarnoff SJ (1962). Functional sympatholysis during muscular activity. Observations on influence of carotid sinus on oxygen uptake. Circ Res 11, 370-380.
31. Rongen GA, Smits P & Thien T (1994). Characterization of ATP-induced vasodilation in the human forearm vascular bed. Circulation 90, 1891-1898.
32. 2-adrenergic vasoconstriction is blunted in contracting human muscle. J Physiol 547, 971-976.
33. Rosenmeier JB, Dinenno FA & Joyner MJ (2003 b). Exogenous NO administration and alpha adrenergic vasoconstriction in human limbs. J Appl Physiol 95, 2370-2374.
34. Rosenmeier JB, Hansen J & González-Alonso J (2004). Circulating ATP-induced vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal muscle. J Physiol 558, 351-365.
35. Thomas GD & Segal SS (2004). Neural control of muscle blood flow during exercise. J Appl Physiol 15, 893-901.
36. Thomas GD & Victor RG (1998). Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Physiol 506, 817-826.
37. Tschakovsky ME, Sujirattanawimol K, Ruble SB, Valic Z & Joyner MJ (2002). Is sympathetic neural vasoconstriction blunted in the vascular bed of exercising human muscle? J Physiol 541, 623-635.
38. van Ginneken EE, Meijer P, Verkaik N, Smits P & Rongen GA (2004). ATP-induced vasodilation in human skeletal muscle. Br J Pharmacol 141, 842-850.
39. Vassort G (2001). Adenosine 5′-triphosphate: A P2-purinergic agonist in the myocardium. Physiol Rev 81, 767-806.
40. Wang L, Karlsson L, Moses S, Hultgardh-Nilsson A, Andersson M, Borna C, Gudbjartsson T, Jern S & Erlinge D (2002). P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 40, 841-853.
41. Wihlborg AK, Balogh J, Wang L, Borna C, Dou Y, Joshi BV, Lazarowski E, Jacobson KA, Arner A & Erlinge D (2006). Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y 2 and P2Y 6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction. Circ Res 98, 970-976.
42. Wihlborg AK, Malmsjo M, Eyjolfsson A, Gustafsson R, Jacobson K & Erlinge D (2003). Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium-derived hyperpolarising factor. Br J Pharmacol 138, 1451-1458.
43. Winter P & Dora KA (2007). Spreading dilatation to luminal perfusion of ATP and UTP in rat isolated small mesenteric arteries. J Physiol 582, 335-347.
44. Yegutkin GG (2008). Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta 1783, 673-694.
45. Yegutkin GG, Bodin P & Burnstock G (2000). Effects of shear stress on the release of soluble ecto-enzymes ATPase and 5′-nucleotidase along with endogenous ATP from vascular endothelial cells. Br J Pharmacol 129, 921-926.
46. Yegutkin GG, Samburski SS & Jalkanen S (2003). Soluble purine-converting enzyime circulate in human blood and regulate extracellular ATP level via counteracting pyrophosphatase and phosphotransfer reactions. FASEB J 17, 1328-1330.
47. Yegutkin GG, Samburski SS, Mortensen SP, Jalkanen S & González-Alonso J (2007). Intravascular ADP and soluble nucleotidases contribute to acute prothrombotic state during vigorous exercise in humans. J Physiol 579, 553-564.
48. Zimmermann H (2006). Ectonucleotidases in the nervous system. Novartis Found Symp 276, 113-128; Discussion 128-130, 233-237, 275-281.